CDER compliance personnel
Manufacturing and Product Quality Division Investigations and Pre-approval Compliance Branch Chief Mark Lynch is leaving to join the consulting firm KMI Paraxel. Effective March 1, Pat Alcock of the foreign inspection team will serve as acting branch chief for two months. Fred Blumenschein has been named the new chief of the case management and guidance branch in DMPQ, and Nick Buhay is the new deputy director of the Manufacturing and Product Quality Control Division
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth